Navigation Links
Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza

GAITHERSBURG, Md., April 25, 2013 /PRNewswire/ -- Quanta BioSciences today announced the CDC Real-Time RT-PCR (rRT-PCR) Protocol LP-152 for Detection and Characterization of Avian A/H7 (Eurasian-lineage) Influenza recommends that public health and other qualified laboratories utilize Quanta's qScript One-Step qRT-PCR Kit, Low ROX (95059-200 and 95059-050).

According to the World Health Organization (WHO) 108 cases of H7N9 influenza have been reported in China, causing severe respiratory illness including 22 deaths, as of April 23. Whether person-to-person transmission of this virus is possible is unclear, but other strains of Avian Influenza A, such as H5N1, have been spread via human-to-human interaction. With the potential threat of pandemic presented by any flu virus that can spread human-to-human, it is imperative that the best technologies are employed to detect and characterize these viruses.

In an effort to make supply of the qScript One-Step qRT-PCR technology available across the globe in reaction to the H7N9 outbreak, Quanta BioSciences has engaged its worldwide distribution network to ensure steady supply. For more information on this technology or to determine how to source these kits, please visit

About Quanta Biosciences:

Quanta BioSciences Inc., a U.S. based company, supplies superior quality reagents for demanding RT and PCR applications in life science, drug discovery and public health laboratories around the world. The Quanta BioSciences PCR and cDNA synthesis reagent portfolio defines the standard for reproducibility, specificity and sensitivity in the quantitative PCR market. The qScript technology named in CDC protocol LP-152 is part of a large family of polymerases designed and built for robust quantitative amplification and detection.

Media Contact: Will Geist , Quanta BioSciences, +1 800-364-2149, ext. 702 or email 

SOURCE Quanta BioSciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Quantason Names Dr. Ellen B. Mendelson, Medical Director
2. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
3. Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference
4. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
5. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
6. Northstar Biosciences Launches All Natural Skincare Solutions
7. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
8. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
9. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture
Post Your Comments:
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
(Date:11/25/2015)... 2015 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... fireside chat discussion at the Piper Jaffray 27th Annual ... The discussion is scheduled for Wednesday, December 2, at ... A replay will be available for 14 days after ... Julie NormartVP, Corporate Communications and Business Development , BrewLife(858) ...
(Date:11/24/2015)... 2015  Asia-Pacific (APAC) holds the third-largest share ... The trend of outsourcing to low-cost locations is ... volume share for the region in the short ... in the CRO industry will improve. ... ), finds that the market earned revenues ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/19/2015)... 19, 2015  Although some 350 companies are actively ... a few companies, according to Kalorama Information. These include Roche ... the market share of the 6.1 billion-dollar molecular testing ... Market for Molecular Diagnostic s .    ... still controlled by one company and only a handful ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
Breaking Biology News(10 mins):